Flu vaccine: FDA approves FLUAD® QUADRIVALENT for adults 65 years and older
by Press Release from Outbreak News Today on (#4ZYES)
By NewsDesk @infectiousdiseasenews Seqirus announced this week that the U.S. Food and Drug Administration (FDA) has approved the first adjuvanted quadrivalent influenza vaccine, FLUAD(R) QUADRIVALENT (Influenza Vaccine, Adjuvanted), to help protect adults 65 years and older against seasonal influenza. "Adults 65 years and older are at high risk for influenza-related complications each season and it is important ["]
The post Flu vaccine: FDA approves FLUAD(R) QUADRIVALENT for adults 65 years and older appeared first on Outbreak News Today.